Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.75
Bid: 5.60
Ask: 5.90
Change: -0.075 (-1.29%)
Spread: 0.30 (5.357%)
Open: 5.825
High: 0.00
Low: 0.00
Prev. Close: 5.825
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

23 Mar 2007 18:19

Plant Health Care PLC23 March 2007 TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii): PLANT HEALTH CARE 2. Reason for the notification (please state Yes/No): An acquisition or disposal of voting rights: An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: An event changing the breakdown of voting rights: Other (please specify): (YES) Notification for the FSA 20 March 2007 deadline 3. Full name of person(s) subject to the notification obligation (iii): Gartmore Investment Limited 4. Full name of shareholder(s) (if different from 3.) (iv): The Alphagen Volantis Fund Limited 3.116% 5. Date of the transaction (and date on which the threshold is crossed or reached if different) (v): 6. Date on which issuer notified: 19 March 2007 7. Threshold(s) that is/are crossed or reached: 5% 8. Notified details: A: Voting rights attached to shares Class/type of shares Situation previous if possible using to the Triggering transaction (vi)the ISIN CODE Number of shares Number of voting Rights (viii)--------------------------------------------------------------------------------GB00B01JC540 3,415,820 8% Resulting situation after the triggering transaction (vii) Number of shares Number of voting rights (ix) % of voting rights------------------------------------------------------------------------------ Direct Direct (x) Indirect (xi) Direct Indirect 3,415,820 3,415,820 8.142% B: Financial Instruments Resulting situation after the triggering transaction (xii)Type of Expiration Date Exercise/Conversion Number of voting % of votingfinancial (xiii) Period/Date (xiv) rights that may be rightsinstrument acquired if the instrument is exercised/ converted. Total (A+B)Number of voting rights % of voting rights3,415,820 8.142% 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable (xv): Proxy Voting: 10. Name of the proxy holder: n/a. 11. Number of voting rights proxy holder will cease to hold: n/a 12. Date on which proxy holder will cease to hold voting rights: n/a 13. Additional information: 14. Contact name: Andrew Wood 15. Contact telephone number: +44 (0)20 8866 5702 Annex to Notification Of Major Interests In Shares (xvi) A: Identity of the person or legal entity subject to the notification obligation Full name (including legal form for legal entities): Gartmore Investment Limited Contact address (registered office for legal entities): Gartmore House, 8 Fenchurch Place, London EC3M 4PB Phone number: +44 (0)20 7782 2324 Other useful information (at least legal representative for legal persons): Alison Averono B: Identity of the notifier, if applicable (xvii) Full name: Contact address: Phone number: Other useful information (e.g. functional relationship with the person or legalentity subject to the notification obligation) Notes to the Forms (i) This form is to be sent to the issuer or underlying issuer and to be filedwith the competent authority. (ii) Either the full name of the legal entity or another method for identifyingthe issuer or underlying issuer, provided it is reliable and accurate. (iii) This should be the full name of (a) the shareholder; (b) the personacquiring, disposing of or exercising voting rights in the cases provided for inDTR5.2.1 (b) to (h); (c) all the parties to the agreement referred to inDTR5.2.1 (a), or (d) the direct or indirect holder of financial instrumentsentitled to acquire shares already issued to which voting rights are attached,as appropriate. In relation to the transactions referred to in points DTR5.2.1 (b) to (h), thefollowing list is provided as indication of the persons who should be mentioned: - in the circumstances foreseen in DTR5.2.1 (b), the person that acquires thevoting rights and is entitled to exercise them under the agreement and thenatural person or legal entity who is transferring temporarily for considerationthe voting rights; - in the circumstances foreseen in DTR 5.2.1 (c), the person holding thecollateral, provided the person or entity controls the voting rights anddeclares its intention of exercising them, and person lodging the collateralunder these conditions; - in the circumstances foreseen in DTR5.2.1(d), the person who has a lifeinterest in shares if that person is entitled to exercise the voting rightsattached to the shares and the person who is disposing of the voting rights whenthe life interest is created; - in the circumstances foreseen in DTR5.2.1 (e), the parent undertaking and,provided it has a notification duty at an individual level under DTR 5.1, underDTR5.2.1 (a) to (d) or under a combination of any of those situations, thecontrolled undertaking; - in the circumstances foreseen in DTR5.2.1 (f), the deposit taker of theshares, if he can exercise the voting rights attached to the shares depositedwith him at his discretion, and the depositor of the shares allowing the deposittaker to exercise the voting rights at his discretion; - in the circumstances foreseen in DTR5.2.1 (g), the person that controls thevoting rights; - in the circumstances foreseen in DTR5.2.1 (h), the proxy holder, if he canexercise the voting rights at his discretion, and the shareholder who has givenhis proxy to the proxy holder allowing the latter to exercise the voting rightsat his discretion. (iv) Applicable in the cases provided for in DTR 5.2.1 (b) to (h). This shouldbe the full name of the shareholder who is the counterparty to the naturalperson or legal entity referred to in DTR5.2. (v) The date of the transaction should normally be, in the case of an onexchange transaction, the date on which the matching of orders occurs; in thecase of an off exchange transaction, date of the entering into an agreement. The date on which threshold is crossed should normally be the date on which theacquisition, disposal or possibility to exercise voting rights takes effect (seeDTR 5.1.1R (3)). For passive crossings, the date when the corporate event tookeffect. (vi) Please refer to the situation disclosed in the previous notification, Incase the situation previous to the triggering transaction was below 3%, pleasestate 'below 3%'. (vii) If the holding has fallen below the minimum threshold , the notifyingparty should not be obliged to disclose the extent of the holding, only that thenew holding is less than 3%. For the case provided for in DTR5.2.1(a), there should be no disclosure ofindividual holdings per party to the agreement unless a party individuallycrosses or reaches an Article 9 threshold. This applies upon entering into,introducing changes to or terminating an agreement. (viii) Direct and indirect (ix) In case of combined holdings of shares with voting rights attached 'directholding' and voting rights 'indirect holdings', please split the voting rightsnumber and percentage into the direct and indirect columns-if there is nocombined holdings, please leave the relevant box blank. (x) Voting rights to shares in respect of which the notifying party is a directshareholder (DTR 5.1) (xi) Voting rights held by the notifying party as an indirect shareholder (DTR5.2.1) (xii) If the holding has fallen below the minimum threshold, the notifying partyshould not be obliged to disclose the extent of the holding, only that the newholding is below 3%. (xiii) date of maturity / expiration of the finical instrument i.e. the datewhen the right to acquire shares ends. (xiv) If the financial instrument has such a period-please specify the period-for example once every three months starting from the (date) (xv) The notification should include the name(s) of the controlled undertakingsthrough which the voting rights are held. The notification should also includethe amount of voting rights and the percentage held by each controlledundertaking, insofar as individually the controlled undertaking holds 5% ormore, and insofar as the notification by the parent undertaking is intended tocover the notification obligations of the controlled undertaking. (xvi ) This annex is only to be filed with the competent authority. (xvii) Whenever another person makes the notification on behalf of theshareholder or the natural person/legal entity referred to in DTR5.2 and DTR5.3 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
31st May 20245:05 pmRNSFull Year Results
16th May 20242:24 pmRNSHolding(s) in Company
14th May 20242:58 pmRNSHolding(s) in Company
8th May 20247:00 amRNSTrading Update
22nd Apr 20247:00 amRNSApproval of Harpinαβ in Belgium
16th Apr 20247:00 amRNSPlant Health Care--China Distribution with AMVAC
4th Apr 20247:00 amRNSApproval of PHC68949 in Mexico
4th Mar 20241:55 pmRNSHolding(s) in Company
24th Jan 20244:27 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSBrazil approves TEIKKOâ„¢
20th Dec 20237:00 amRNSBoard Changes and Grant of Options
19th Dec 20233:34 pmRNSHolding(s) in Company
30th Nov 20231:45 pmRNSHolding(s) in Company
28th Nov 20233:16 pmRNSHolding(s) in Company
27th Nov 20234:03 pmRNSHolding(s) in Company
27th Nov 20231:27 pmRNSHolding(s) in Company
24th Nov 20234:19 pmRNSDirector/PDMR Shareholding
24th Nov 202310:57 amRNSDirector/PDMR Shareholding
23rd Nov 20232:31 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSTrading Update
31st Oct 20237:00 amRNSChange of Adviser
20th Oct 20237:00 amRNSHolding(s) in Company
3rd Oct 20236:28 pmRNSPlant Health Care PREtec Product with Agrii UK
28th Sep 20237:00 amRNSNew PREtec Products Announced
27th Sep 20237:00 amRNSUnaudited Interim Results
25th Sep 20237:00 amRNSPREtec Products Submitted for Regulatory Approval
31st Aug 20237:00 amRNSNotice of Results & Investor Presentation
18th Aug 20237:00 amRNSNew Product Regulatory Approval In Brazil
1st Aug 20237:00 amRNSApproval for Sale of Harpin aß Granted in Poland
24th Jul 20237:00 amRNSGrant of Options
12th Jul 202312:27 pmRNSHolding(s) in Company
30th Jun 20235:07 pmRNSNotification of Major Holdings
28th Jun 202312:29 pmRNSHolding(s) in Company
27th Jun 20234:08 pmRNSHolding(s) in Company
27th Jun 20231:08 pmRNSDirector Shareholding
23rd Jun 20237:00 amRNSResult of Fundraising
22nd Jun 20234:35 pmRNSFundraising to raise up to US$3.6 million
14th Jun 20237:00 amRNSWilbur Ellis Agreement
13th Jun 20231:43 pmRNSResult of AGM
30th May 20237:00 amRNSHolding(s) in Company
24th May 20231:12 pmRNSHolding(s) in Company
19th May 20235:55 pmRNSPublication of Annual Report and Notice of AGM
18th May 20237:00 amRNSResult of Consultation
9th May 20237:00 amRNSPHC68949 granted first stage of approval in Brazil
2nd May 20237:10 amRNSResults for the year ended 31 December 2022
12th Apr 20232:33 pmRNSNotice of Results
5th Apr 20235:29 pmRNSHolding(s) in Company
8th Mar 20232:45 pmRNSExercise of Options
2nd Mar 20237:00 amRNSBiofungicide PHC279 Approved by US EPA
1st Mar 20237:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.